secwatch.observer — SEC 8-K summary
======================================

Issuer:     Actinium Pharmaceuticals, Inc. (ATNM)
CIK:        0001388320
Form:       8-K
Filed at:   2026-02-13T23:59:59+00:00
Accession:  0001213900-26-016559
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Actinium CFO Steve O'Loughlin resigns; CEO Sandesh Seth named principal financial officer
--------------------------------------------------------------------------------

- Steve O'Loughlin resigns as CFO effective Feb 27, 2026 to pursue other opportunities.
- No disagreements with the company contributed to his resignation.
- Board appoints CEO/Chairman Sandesh Seth as principal financial officer effective same date.
- Sandesh Seth has 25+ years in pharma, investment banking, and equity research.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388320/000121390026016559/0001213900-26-016559-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388320/000121390026016559/ea0277127-8k_actinium.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-016559

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer